AM

Ambarish Mahanta

Active Director Additional Director DIN 09780422
DIN 09780422 First appointment Nov 2022 Primary industry Electrnoics
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Ambarish Mahanta

Data last updated:

Ambarish Mahanta is an Additional Director at Zeedaa Lifescience Private Limited (since 2022). The company operates in Electrnoics.

DIN 09780422
Primary Designation Additional Director
Industry Electrnoics
First Appointment 02 Nov 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Zeedaa Lifescience Private Limited U52609AS2022PTC023333
Additional Director02 Nov 20222022Active

Board colleagues of Ambarish Mahanta

Directorship timeline

Open interactive timeline →
Zeedaa Lifescience Private Limited
Premium access

Shareholding and investment profile for Ambarish Mahanta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ambarish Mahanta

Ambarish Mahanta currently holds 1 directorship: Zeedaa Lifescience Private Limited (Additional Director, since 02 Nov 2022).

Ambarish Mahanta was first appointed on 02 Nov 2022 as Additional Director at Zeedaa Lifescience Private Limited.

The current boards of Ambarish Mahanta's companies include Kishor Kumar Dutta (Zeedaa Lifescience Private Limited), Mrinmoy Mahanta (Zeedaa Lifescience Private Limited), Nitish Kapoor (Zeedaa Lifescience Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available